⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6573644 | 0.96 | — | — | |
| SCHEMBL9506231 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL9065906 | 0.73 | — | — | |
| SCHEMBL1767851 | 0.72 | — | — | |
| SCHEMBL2049633 | 0.69 | — | — | |
| SCHEMBL997516 | 0.67 | — | — | |
| SCHEMBL15581868 | 0.67 | — | — | |
| SCHEMBL2522901 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL4572764 | 0.67 | — | — | |
| SCHEMBL15377303 | 0.65 | OPRM1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | claimed |
| JP-2008543297-A | — | — | 2008-12-04 | — | — | JP | claimed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | claimed |
| EP-1893239-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF GROWTH HORMONE | Novo Nordisk Health Care AG (CH) | 2008-03-05 | — | — | EP | claimed |
| JP-2007518747-A | — | — | 2007-07-12 | — | — | JP | claimed |
| WO-2006134148-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF GROWTH HORMONE | NOVO NORDISK HEALTH CARE AG (DK) | 2006-12-21 | — | — | WO | claimed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | claimed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | claimed |
| EP-3240806-B1 | GRAFT COPOLYMER | GALDERMA SA (CH) | 2021-07-14 | — | — | EP | disclosed |
| US-10745493-B2 | Graft copolymer | GALDERMA S.A. (CH) | 2020-08-18 | — | — | US | disclosed |
| US-20180221438-A1 | MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2018-08-09 | — | — | US | disclosed |
| US-20180002454-A1 | GRAFT COPOLYMER | GALDERMA S.A. (CH) | 2018-01-04 | — | — | US | disclosed |
| EP-3240806-A1 | GRAFT COPOLYMER | Galderma S.A. (CH) | 2017-11-08 | — | — | EP | disclosed |
| WO-2016172795-A1 | MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF | Adaerata Limited Partnership (CA) | 2016-11-03 | — | — | WO | disclosed |
| EP-1850878-A2 | C-TERMINALLY PEGYLATED GROWTH HORMONES | NOVO NORDISK A/S (DK) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006134148-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF GROWTH HORMONE | NOVO NORDISK HEALTH CARE AG (DK) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006135763-A2 | INHIBITORS OF DNA REPAIR ENZYMES AND METHODS OF USE THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2006-12-21 | — | — | WO | disclosed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | disclosed |
| WO-2006084888-A2 | C-TERMINALLY PEGYLATED GROWTH HORMONES | NOVO NORDISK A/S (DK) | 2006-08-17 | — | — | WO | disclosed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | disclosed |